Fos-Related Antigen 1 Modulates Malignant Features of Glioma Cells
- 1 April 2005
- journal article
- Published by American Association for Cancer Research (AACR) in Molecular Cancer Research
- Vol. 3 (4), 237-249
- https://doi.org/10.1158/1541-7786.mcr-05-0004
Abstract
Malignant gliomas, and high-grade gliomas (HGG) in particular, are nonmetastasizing but locally infiltrating, hypervascularized brain tumors of poor prognosis. We found previously that a c-fos-inducible vascular endothelial growth factor D is ubiquitously up-regulated in HGG grade IV, glioblastoma multiforme, and that glioblastoma multiforme overexpress Fos-related antigen 1 (Fra-1) rather than the c-Fos. We have thus become interested in the role Fra-1 may play in malignant glioma progression/maintenance, because Fra-1 has the capacity to modulate transcription of a variety of target genes. In this work, we have analyzed the biological effects of ectopic Fra-1 expression or Fra-1 knockdown in malignant glioma cells. Ectopic Fra-1 induced prominent phenotypic changes in all three malignant glioma cell lines examined: H4, U-87 MG, and A-172 MG. These changes were reflected in cells becoming more elongated with larger number of cellular processes. Furthermore, Fra-1 transgene caused H4 cells, which do not form tumor xenografts, to regain tumorigenic capacity. The genotype of these cells changed too, because 50 of 1,056 genes examined became either up-regulated or down-regulated. Conversely, Fra-1 knockdown altered prominently the morphology, anchorage-independent growth, tumorigenic potential, and Fra-1 effector expression, such as vascular endothelial growth factor D, in HGG cells. For example, cells transfected with antisense fra-1 showed shorter cellular processes than the control cells that did not grow in agar, and their tumorigenic potential was significantly diminished. Thus, Fra-1 may likely play an important role in the maintenance/progression of malignant gliomas and potentially represents a new target for therapeutic interventions.Keywords
This publication has 36 references indexed in Scilit:
- Role of the Fos family members, c-Fos, Fra-1 and Fra-2, in the regulation of cell motilityOncogene, 2003
- AP-1 in mouse development and tumorigenesisOncogene, 2001
- Matrix Metalloproteinase 9 Promoter Activity Is Induced Coincident with Invasion during Tumor ProgressionThe American Journal of Pathology, 2000
- Transcriptional regulation of cell invasion: AP-1 regulation of a multigenic invasion programmeEuropean Journal Of Cancer, 2000
- High levels of phosphorylated c-Jun, Fra-1, Fra-2 and ATF-2 proteins correlate with malignant phenotypes in the multistage mouse skin carcinogenesis modelOncogene, 2000
- Fosl1 is a transcriptional target of c-Fos during osteoclast differentiationNature Genetics, 2000
- Increase in AP-1 activity is a general event in thyroid cell transformation in vitro and in vivoOncogene, 1998
- Survival rates in patients with primary malignant brain tumors stratified by patient age and tumor histological type: an analysis based on Surveillance, Epidemiology, and End Results (SEER) data, 1973–1991Journal of Neurosurgery, 1998
- Chromosome Mapping and Expression of the Human Interleukin-13 ReceptorGenomics, 1997
- The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformationBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1991